A study published in JAMA Ophthalmology looks at optic neuropathy as a possible side effect of semaglutide. Prof Graham McGeown, … read more
A study published in JAMA Ophthalmology looks at the risk of ocular adverse events associated with the use of phosphodiesterase … read more
An observational study published in British Journal of Ophthalmology looks at myopia (short-sightedness) incidence and lifestyle changes among school children … read more
A case study published in Nature Medicine follows the partial recovery of visual function in a blind patient after optogenetic therapy. … read more
A study published in the British Journal of Ophthalmology suggests air pollution is linked to higher risk of sight loss … read more
There have been questions from journalists regarding the claims of Dominic Cummings and Boris Johnson around the affect of COVID-19 … read more
A study, published in the Journal of Investigative Medicine, reports a link between long term exposure to pollutants from vehicle … read more
Two papers published in Nature Medicine looked at deep-learning analyses, one of CT scans and one of eye scans. read more
Scientists examine the association between drinking tea every day and lower glaucoma risk, in a new study, published in the British Journal of Ophthalmology.
read more
A new study, published in PNAS, reports the use of gene therapy to improve visual function in a mouse model of retinal degeneration. read more
Publishing in Stem Cell Reports, a group of researchers have reported that retinal tissue derived from mouse induced pluriopotent stem cells (iPSCs) established connections with neighbouring cells and responded to light stimulation, restoring visual fuction in half of mice with end-stage retinal degeneration. read more
The use of the genome editing technique CRISPR/Cas9 in blind rodents is described by scientists publishing in the journal Nature with the authors reporting their introduction of a corrected gene to the eyes of the blind rats which partially improved vision. read more
A study published in Nature Biotechnology has shown that photoreceptor cells, grown in the lab from mouse embryonic stem cells, can be transplanted into mice retinas and successfully integrate there, illustrating that some types of blindness might be responsive to cell therapy. read more
A study in JAMA Internal Medicine found regular aspirin use appears to be associated with an increased risk of age-related macular degeneration (AMD), which is a leading cause of blindness in older people. read more
The British Union for the Abolition of Vivisection (BUAV) condemned research at Cardiff University looking into the causes of amblyopia, or lazy eye, in which newborn kittens had one eyelid sewn shut.
read more
Research demonstrating the feasibility of restoring vision after retinal degeneration by transplanting photoreceptor cells was published in Nature, by demonstrating functional vision in visually impaired adult mice having undergone transplantation.
read more
A paper published in The Lancet established the safety of a stem cell treatment for macular degeneration after a phase 1 clinical trial. read more
A paper published in The Lancet established the safety of a stem cell treatment for macular degeneration after a phase 1 clinical trial. read more
American biotechnology company Advanced Cell Technology (ACT) announced the launch of a clinical trial for a stem cell treatment for Stargard’s Disease, a condition that causes progressive blindness. read more
Scientists react to announcement of the start of a new trial to use gene therapy to treat blindness in children. read more